COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition: AnemiaInterventions: Drug: darbepoetin alfa; Drug: epoetin beta [NeoRecormon]Sponsor: Hoffmann-La RocheCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials
Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia
Conditions: Anemia; NeoplasmsInterventions: Drug: Darbepoetin alfa; Drug: Epoetin alfaSponsor: Janssen-Cilag B.V.Completed - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2005 Category: Research Source Type: clinical trials
